Showing results (31-40 of 121) with videos related to
Sort By:
Pageof 13
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 12, 2021
Identification of Human UDP-Glucuronosyltransferase and Sulfotransferase as Responsible for the Metabolism of Dotinurad, a Novel Selective Urate Reabsorption InhibitorKoichi Omura, Keisuke Motoki, Seiichi Kobashi, et al.BMC Pulmonary Medicine|January 7, 2021
Pneumothorax in patients with idiopathic pulmonary fibrosis: a real-world experienceRyo Yamazaki, Osamu Nishiyama, Kyuya Gose, et al.Plos One|January 22, 2021
HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failureRyo Yamazaki, Osamu Nishiyama, Kazuya Yoshikawa, et al.International Immunopharmacology|August 27, 2009
Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medicationMasato Muraki, Shu Imbe, Ryuji Sato, et al.Bioorganic & Medicinal Chemistry Letters|November 26, 2008
Design, synthesis, and pharmacological and pharmacokinetic evaluation of 3-phenyl-5-pyridyl-1,2,4-triazole derivatives as xanthine oxidoreductase inhibitorsTakahiro Sato, Naoki Ashizawa, Takashi Iwanaga, et al.Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Discovery of 3-(2-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051 - a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia [corrected]Takahiro Sato, Naoki Ashizawa, Koji Matsumoto, et al.Respirology (Carlton, Vic.)|November 22, 2016
Fat-free mass index predicts survival in patients with idiopathic pulmonary fibrosisOsamu Nishiyama, Ryo Yamazaki, Hiroyuki Sano, et al.Pharmacology Research & Perspectives|December 3, 2019
Pharmacokinetic/pharmacodynamic modeling and simulation of dotinurad, a novel uricosuric agent, in healthy volunteersKeisuke Motoki, Takako Igarashi, Koichi Omura, et al.Journal of Bone and Mineral Metabolism|February 4, 2019
Novel bisphosphonate compound FYB-931 preferentially inhibits aortic calcification in vitamin D3-treated ratsKoichi Ishida, Naoki Ashizawa, Koji Matsumoto, et al.Canadian Respiratory Journal|July 23, 2016
Pulmonary Hemodynamics and Six-Minute Walk Test Outcomes in Patients with Interstitial Lung DiseaseOsamu Nishiyama, Ryo Yamazaki, Hiroyuki Sano, et al.Pageof 13